GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ALDX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for Aldeyra Therapeutics as stock downgraded to Hold/Accumulate.
(Updated on Apr 18, 2024)

Buy or Hold candidate since Apr 02, 2024 Gain 12.11% PDF

The Aldeyra Therapeutics stock price gained 0.252% on the last trading day (Thursday, 18th Apr 2024), rising from $3.97 to $3.98. During the last trading day the stock fluctuated 4.63% from a day low at $3.89 to a day high of $4.07. The price has been going up and down for this period, and there has been a -15.05% loss for the last 2 weeks. Volume fell on the last day by -205 thousand shares and in total, 427 thousand shares were bought and sold for approximately $1.70 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 20.65% during the next 3 months and, with a 90% probability hold a price between $3.71 and $5.84 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ALDX Signals & Forecast

The Aldeyra Therapeutics stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $4.13. On a fall, the stock will find some support from the long-term average at approximately $3.62. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, April 05, 2024, and so far it has fallen -15.68%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Aldeyra Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.62 and $3.55. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Aldeyra Therapeutics finds support just below today's level at $3.62. If this is broken, then the next support from accumulated volume will be at $3.55 and $3.27.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.180 between high and low, or 4.63%. For the last week, the stock has had daily average volatility of 6.64%.

Our recommended stop-loss: $3.77 (-5.24%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (ALDX) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Aldeyra Therapeutics to open at $3.98, and during the day (based on 14 day Average True Range), to move between $3.68 and $4.28, which gives a possible trading interval of +/-$0.303 (+/-7.62%) up or down from last closing price. If Aldeyra Therapeutics takes out the full calculated possible swing range there will be an estimated 15.24% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.15 (4.27%) than the support at $3.62 (9.05%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Aldeyra Therapeutics stock A Buy?

Aldeyra Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.397 Hold/Accumulate Downgraded

Predicted Opening Price for Aldeyra Therapeutics of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$3.98 ( 0.00000000%) $3.98

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ALDX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.16 4.52 %
R2 4.09 2.79 %
R1 4.05 1.73 %
Current price: 3.98
Support S1 3.91 -1.73 %
S2 3.87 -2.79 %
S3 3.80 -4.52 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.72 18.59 %
R2 4.69 17.71 %
R1 4.15 4.27 %
Current price 3.98
Support S1 3.62 -9.05%
S2 3.55 -10.80%
S3 3.27 -17.84%

FAQ

What is the symbol for Aldeyra Therapeutics Stock and on which exchange is it traded?
The symbol for Aldeyra Therapeutics is ALDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aldeyra Therapeutics Stock?
Aldeyra Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Aldeyra Therapeutics Stock?
Aldeyra Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aldeyra Therapeutics Stock.

What's the current price of Aldeyra Therapeutics Stock?
As of the end of day on the 2024-04-18, the price of an Aldeyra Therapeutics (ALDX) share was $3.98.

What is the 52-week high and low for Aldeyra Therapeutics Stock?
The 52-week high for Aldeyra Therapeutics Stock is $11.97 and the 52-week low is $1.42.

What is the market capitalization of Aldeyra Therapeutics Stock?
As of the 2024-04-18, the market capitalization of Aldeyra Therapeutics is 234.405M.

When is the next earnings date for Aldeyra Therapeutics?
The upcoming earnings date for Aldeyra Therapeutics is May 02, 2024.
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT